Skip to content
InsideEdge
Investors / filer profile

No completed buy history yet — outcomes appear once a disclosed buy is ~6 months old.

Disclosed positions

Estimated from their latest filings — positions may have changed since

$787.5K
combined est. value

Activity

Open-market buy & sell volume

BuySell
0$834K$1.7M2025 · bought $0 · sold $1.7M20252026 · bought $0 · sold $848K2026
Total +$0.0000 bought · $2.52M sold

All filings on record

Every Form 4 transaction we track for this filer

KNSASell
2026-02-12 · Kiniksa Pharmaceuticals International, plc
$121.0K
KNSAExercise
2026-02-12 · Kiniksa Pharmaceuticals International, plc
$41.6K
KNSASell
2026-02-10 · Kiniksa Pharmaceuticals International, plc
$5.0K
KNSAExercise
2026-02-10 · Kiniksa Pharmaceuticals International, plc
$1.7K
KNSASell
2026-02-04 · Kiniksa Pharmaceuticals International, plc
$117.1K
KNSAExercise
2026-02-04 · Kiniksa Pharmaceuticals International, plc
$40.3K
KNSASell
2026-02-03 · Kiniksa Pharmaceuticals International, plc
$567.1K
KNSAExercise
2026-02-03 · Kiniksa Pharmaceuticals International, plc
$193.8K
KNSASell
2026-02-02 · Kiniksa Pharmaceuticals International, plc
$37.4K
KNSAExercise
2026-02-02 · Kiniksa Pharmaceuticals International, plc
$12.8K
KNSASell
2025-12-15 · Kiniksa Pharmaceuticals International, plc
$835.6K
KNSAExercise
2025-12-15 · Kiniksa Pharmaceuticals International, plc
$208.5K
KNSASell
2025-06-11 · Kiniksa Pharmaceuticals International, plc
$374.9K
KNSAExercise
2025-06-11 · Kiniksa Pharmaceuticals International, plc
$46.9K
KNSASell
2025-06-10 · Kiniksa Pharmaceuticals International, plc
$249.3K
KNSAExercise
2025-06-10 · Kiniksa Pharmaceuticals International, plc
$31.2K
KNSASell
2025-06-09 · Kiniksa Pharmaceuticals International, plc
$208.8K
KNSAExercise
2025-06-09 · Kiniksa Pharmaceuticals International, plc
$26.2K
KNSAExercise
2025-06-05 · Kiniksa Pharmaceuticals International, plc
3,173

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.